Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Endometriosis is very painful and can lead to infertility. It affects the outline tissue of the uterus and causes internal bleeding and inflammation. The global endometriosis market size is expected to expand by 2025. Symptoms of endometriosis are, for example, pain before and during the menstrual period, pain during ovulation and irregular or massive bleeding over some time, resulting in a significant reduction in the working female population. High prevalence, unknown etiology, and high productivity loss are the main factors that have led many research institutions and drug manufacturers to research the best diagnosis and treatment of the disease.
Gonadotropin-releasing hormone agonists, oral contraceptives, and progestin therapy are widely used for pain after diagnosis. The market share of non-steroidal anti-inflammatory drugs accounts for the major share of the global endometriosis market and is expected to maintain its dominant position. The supply of a large number of brands and generic products is expected to drive the growth of market segments soon.
In developed and developing countries, the increase in the female population aged 15-49 years is expected to drive the growth of the endometriosis drug market. It is expected that the high prevalence of endometriosis among women of childbearing age will drive the market demand for endometriosis treatment in the next few years. The growth of the female population during childbearing age, women's awareness of this disease continues to increase, and the development of new drugs for the treatment of endometriosis are some of the factors that have contributed to market growth. However, it takes more than seven years to diagnose the disease, and the lack of non-invasive diagnostic tests will increase patient suffering. Therefore, this factor may inhibit the growth of the endometriosis therapy market. Also, many important manufacturers are conducting extensive research in the development of advanced drugs and treatments for endometriosis, taking into account cost management, and such initiatives will drive market growth.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Endometriosis Therapies market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Endometriosis Therapies market. Detailed analysis of key players, along with key growth strategies adopted by Endometriosis Therapies industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
AstraZeneca
Neurocrine Biosciences
Meditrina Pharmaceuticals
Bayer
Takeda Pharmaceutical
AbbVie
Pfizer
Eli Lilly
Astellas Pharma
By Type:
Hormonal Contraceptives
Gonadotropin-releasing Hormone (Gn-RH) Agonists
Progestin Therapy
Aromatase Inhibitors
By End-User:
Hospital
Clinic
Other
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Endometriosis Therapies Market
-
1.3 Market Segment by Type
-
1.3.1 China Endometriosis Therapies Market Size and Growth Rate of Hormonal Contraceptives from 2016 to 2027
-
1.3.2 China Endometriosis Therapies Market Size and Growth Rate of Gonadotropin-releasing Hormone (Gn-RH) Agonists from 2016 to 2027
-
1.3.3 China Endometriosis Therapies Market Size and Growth Rate of Progestin Therapy from 2016 to 2027
-
1.3.4 China Endometriosis Therapies Market Size and Growth Rate of Aromatase Inhibitors from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Endometriosis Therapies Market Size and Growth Rate of Hospital from 2016 to 2027
-
1.4.2 China Endometriosis Therapies Market Size and Growth Rate of Clinic from 2016 to 2027
-
1.4.3 China Endometriosis Therapies Market Size and Growth Rate of Other from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Endometriosis Therapies Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Endometriosis Therapies Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Endometriosis Therapies Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Endometriosis Therapies Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Endometriosis Therapies Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Endometriosis Therapies Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Endometriosis Therapies Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Endometriosis Therapies Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Endometriosis Therapies by Major Types
-
3.4.1 Market Size and Growth Rate of Hormonal Contraceptives
-
3.4.2 Market Size and Growth Rate of Gonadotropin-releasing Hormone (Gn-RH) Agonists
-
3.4.3 Market Size and Growth Rate of Progestin Therapy
-
3.4.4 Market Size and Growth Rate of Aromatase Inhibitors
4 Segmentation of Endometriosis Therapies Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Endometriosis Therapies by Major End-Users
-
4.4.1 Market Size and Growth Rate of Endometriosis Therapies in Hospital
-
4.4.2 Market Size and Growth Rate of Endometriosis Therapies in Clinic
-
4.4.3 Market Size and Growth Rate of Endometriosis Therapies in Other
5 Market Analysis by Regions
-
5.1 China Endometriosis Therapies Production Analysis by Regions
-
5.2 China Endometriosis Therapies Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Endometriosis Therapies Landscape Analysis
-
6.1 North China Endometriosis Therapies Landscape Analysis by Major Types
-
6.2 North China Endometriosis Therapies Landscape Analysis by Major End-Users
7 Central China Endometriosis Therapies Landscape Analysis
-
7.1 Central China Endometriosis Therapies Landscape Analysis by Major Types
-
7.2 Central China Endometriosis Therapies Landscape Analysis by Major End-Users
8 South China Endometriosis Therapies Landscape Analysis
-
8.1 South China Endometriosis Therapies Landscape Analysis by Major Types
-
8.2 South China Endometriosis Therapies Landscape Analysis by Major End-Users
9 East China Endometriosis Therapies Landscape Analysis
-
9.1 East China Endometriosis Therapies Landscape Analysis by Major Types
-
9.2 East China Endometriosis Therapies Landscape Analysis by Major End-Users
10 Northeast China Endometriosis Therapies Landscape Analysis
-
10.1 Northeast China Endometriosis Therapies Landscape Analysis by Major Types
-
10.2 Northeast China Endometriosis Therapies Landscape Analysis by Major End-Users
11 Southwest China Endometriosis Therapies Landscape Analysis
-
11.1 Southwest China Endometriosis Therapies Landscape Analysis by Major Types
-
11.2 Southwest China Endometriosis Therapies Landscape Analysis by Major End-Users
12 Northwest China Endometriosis Therapies Landscape Analysis
-
12.1 Northwest China Endometriosis Therapies Landscape Analysis by Major Types
-
12.2 Northwest China Endometriosis Therapies Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 AstraZeneca
-
13.1.1 AstraZeneca Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Neurocrine Biosciences
-
13.2.1 Neurocrine Biosciences Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Meditrina Pharmaceuticals
-
13.3.1 Meditrina Pharmaceuticals Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Bayer
-
13.4.1 Bayer Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Takeda Pharmaceutical
-
13.5.1 Takeda Pharmaceutical Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 AbbVie
-
13.6.1 AbbVie Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Pfizer
-
13.7.1 Pfizer Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Eli Lilly
-
13.8.1 Eli Lilly Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 Astellas Pharma
-
13.9.1 Astellas Pharma Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Endometriosis Therapies Market Size and Growth Rate of Hormonal Contraceptives from 2016 to 2027
-
Figure China Endometriosis Therapies Market Size and Growth Rate of Gonadotropin-releasing Hormone (Gn-RH) Agonists from 2016 to 2027
-
Figure China Endometriosis Therapies Market Size and Growth Rate of Progestin Therapy from 2016 to 2027
-
Figure China Endometriosis Therapies Market Size and Growth Rate of Aromatase Inhibitors from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Endometriosis Therapies Market Size and Growth Rate of Hospital from 2016 to 2027
-
Figure China Endometriosis Therapies Market Size and Growth Rate of Clinic from 2016 to 2027
-
Figure China Endometriosis Therapies Market Size and Growth Rate of Other from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Endometriosis Therapies Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Endometriosis Therapies Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Endometriosis Therapies Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Endometriosis Therapies Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Endometriosis Therapies Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Endometriosis Therapies Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Endometriosis Therapies Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Endometriosis Therapies Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Endometriosis Therapies
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Endometriosis Therapies by Different Types from 2016 to 2027
-
Table Consumption Share of Endometriosis Therapies by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Hormonal Contraceptives
-
Figure Market Size and Growth Rate of Gonadotropin-releasing Hormone (Gn-RH) Agonists
-
Figure Market Size and Growth Rate of Progestin Therapy
-
Figure Market Size and Growth Rate of Aromatase Inhibitors
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Endometriosis Therapies by Different End-Users from 2016 to 2027
-
Table Consumption Share of Endometriosis Therapies by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospital
-
Figure Market Size and Growth Rate of Clinic
-
Figure Market Size and Growth Rate of Other
-
Table China Endometriosis Therapies Production by Regions
-
Table China Endometriosis Therapies Production Share by Regions
-
Figure China Endometriosis Therapies Production Share by Regions in 2016
-
Figure China Endometriosis Therapies Production Share by Regions in 2021
-
Figure China Endometriosis Therapies Production Share by Regions in 2027
-
Table China Endometriosis Therapies Consumption by Regions
-
Table China Endometriosis Therapies Consumption Share by Regions
-
Figure China Endometriosis Therapies Consumption Share by Regions in 2016
-
Figure China Endometriosis Therapies Consumption Share by Regions in 2021
-
Figure China Endometriosis Therapies Consumption Share by Regions in 2027
-
Table North China Endometriosis Therapies Consumption by Types from 2016 to 2027
-
Table North China Endometriosis Therapies Consumption Share by Types from 2016 to 2027
-
Figure North China Endometriosis Therapies Consumption Share by Types in 2016
-
Figure North China Endometriosis Therapies Consumption Share by Types in 2021
-
Figure North China Endometriosis Therapies Consumption Share by Types in 2027
-
Table North China Endometriosis Therapies Consumption by End-Users from 2016 to 2027
-
Table North China Endometriosis Therapies Consumption Share by End-Users from 2016 to 2027
-
Figure North China Endometriosis Therapies Consumption Share by End-Users in 2016
-
Figure North China Endometriosis Therapies Consumption Share by End-Users in 2021
-
Figure North China Endometriosis Therapies Consumption Share by End-Users in 2027
-
Table Central China Endometriosis Therapies Consumption by Types from 2016 to 2027
-
Table Central China Endometriosis Therapies Consumption Share by Types from 2016 to 2027
-
Figure Central China Endometriosis Therapies Consumption Share by Types in 2016
-
Figure Central China Endometriosis Therapies Consumption Share by Types in 2021
-
Figure Central China Endometriosis Therapies Consumption Share by Types in 2027
-
Table Central China Endometriosis Therapies Consumption by End-Users from 2016 to 2027
-
Table Central China Endometriosis Therapies Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Endometriosis Therapies Consumption Share by End-Users in 2016
-
Figure Central China Endometriosis Therapies Consumption Share by End-Users in 2021
-
Figure Central China Endometriosis Therapies Consumption Share by End-Users in 2027
-
Table South China Endometriosis Therapies Consumption by Types from 2016 to 2027
-
Table South China Endometriosis Therapies Consumption Share by Types from 2016 to 2027
-
Figure South China Endometriosis Therapies Consumption Share by Types in 2016
-
Figure South China Endometriosis Therapies Consumption Share by Types in 2021
-
Figure South China Endometriosis Therapies Consumption Share by Types in 2027
-
Table South China Endometriosis Therapies Consumption by End-Users from 2016 to 2027
-
Table South China Endometriosis Therapies Consumption Share by End-Users from 2016 to 2027
-
Figure South China Endometriosis Therapies Consumption Share by End-Users in 2016
-
Figure South China Endometriosis Therapies Consumption Share by End-Users in 2021
-
Figure South China Endometriosis Therapies Consumption Share by End-Users in 2027
-
Table East China Endometriosis Therapies Consumption by Types from 2016 to 2027
-
Table East China Endometriosis Therapies Consumption Share by Types from 2016 to 2027
-
Figure East China Endometriosis Therapies Consumption Share by Types in 2016
-
Figure East China Endometriosis Therapies Consumption Share by Types in 2021
-
Figure East China Endometriosis Therapies Consumption Share by Types in 2027
-
Table East China Endometriosis Therapies Consumption by End-Users from 2016 to 2027
-
Table East China Endometriosis Therapies Consumption Share by End-Users from 2016 to 2027
-
Figure East China Endometriosis Therapies Consumption Share by End-Users in 2016
-
Figure East China Endometriosis Therapies Consumption Share by End-Users in 2021
-
Figure East China Endometriosis Therapies Consumption Share by End-Users in 2027
-
Table Northeast China Endometriosis Therapies Consumption by Types from 2016 to 2027
-
Table Northeast China Endometriosis Therapies Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Endometriosis Therapies Consumption Share by Types in 2016
-
Figure Northeast China Endometriosis Therapies Consumption Share by Types in 2021
-
Figure Northeast China Endometriosis Therapies Consumption Share by Types in 2027
-
Table Northeast China Endometriosis Therapies Consumption by End-Users from 2016 to 2027
-
Table Northeast China Endometriosis Therapies Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Endometriosis Therapies Consumption Share by End-Users in 2016
-
Figure Northeast China Endometriosis Therapies Consumption Share by End-Users in 2021
-
Figure Northeast China Endometriosis Therapies Consumption Share by End-Users in 2027
-
Table Southwest China Endometriosis Therapies Consumption by Types from 2016 to 2027
-
Table Southwest China Endometriosis Therapies Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Endometriosis Therapies Consumption Share by Types in 2016
-
Figure Southwest China Endometriosis Therapies Consumption Share by Types in 2021
-
Figure Southwest China Endometriosis Therapies Consumption Share by Types in 2027
-
Table Southwest China Endometriosis Therapies Consumption by End-Users from 2016 to 2027
-
Table Southwest China Endometriosis Therapies Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Endometriosis Therapies Consumption Share by End-Users in 2016
-
Figure Southwest China Endometriosis Therapies Consumption Share by End-Users in 2021
-
Figure Southwest China Endometriosis Therapies Consumption Share by End-Users in 2027
-
Table Northwest China Endometriosis Therapies Consumption by Types from 2016 to 2027
-
Table Northwest China Endometriosis Therapies Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Endometriosis Therapies Consumption Share by Types in 2016
-
Figure Northwest China Endometriosis Therapies Consumption Share by Types in 2021
-
Figure Northwest China Endometriosis Therapies Consumption Share by Types in 2027
-
Table Northwest China Endometriosis Therapies Consumption by End-Users from 2016 to 2027
-
Table Northwest China Endometriosis Therapies Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Endometriosis Therapies Consumption Share by End-Users in 2016
-
Figure Northwest China Endometriosis Therapies Consumption Share by End-Users in 2021
-
Figure Northwest China Endometriosis Therapies Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of AstraZeneca
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca
-
Figure Sales and Growth Rate Analysis of AstraZeneca
-
Figure Revenue and Market Share Analysis of AstraZeneca
-
Table Product and Service Introduction of AstraZeneca
-
Table Company Profile and Development Status of Neurocrine Biosciences
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Neurocrine Biosciences
-
Figure Sales and Growth Rate Analysis of Neurocrine Biosciences
-
Figure Revenue and Market Share Analysis of Neurocrine Biosciences
-
Table Product and Service Introduction of Neurocrine Biosciences
-
Table Company Profile and Development Status of Meditrina Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Meditrina Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Meditrina Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Meditrina Pharmaceuticals
-
Table Product and Service Introduction of Meditrina Pharmaceuticals
-
Table Company Profile and Development Status of Bayer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer
-
Figure Sales and Growth Rate Analysis of Bayer
-
Figure Revenue and Market Share Analysis of Bayer
-
Table Product and Service Introduction of Bayer
-
Table Company Profile and Development Status of Takeda Pharmaceutical
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda Pharmaceutical
-
Figure Sales and Growth Rate Analysis of Takeda Pharmaceutical
-
Figure Revenue and Market Share Analysis of Takeda Pharmaceutical
-
Table Product and Service Introduction of Takeda Pharmaceutical
-
Table Company Profile and Development Status of AbbVie
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie
-
Figure Sales and Growth Rate Analysis of AbbVie
-
Figure Revenue and Market Share Analysis of AbbVie
-
Table Product and Service Introduction of AbbVie
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
Table Company Profile and Development Status of Eli Lilly
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly
-
Figure Sales and Growth Rate Analysis of Eli Lilly
-
Figure Revenue and Market Share Analysis of Eli Lilly
-
Table Product and Service Introduction of Eli Lilly
-
Table Company Profile and Development Status of Astellas Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas Pharma
-
Figure Sales and Growth Rate Analysis of Astellas Pharma
-
Figure Revenue and Market Share Analysis of Astellas Pharma
-
Table Product and Service Introduction of Astellas Pharma
-
